D. S. Johnston

Biomarkers and Diagnostics Will Play Essential Roles in Advancing Innovative Contraception

Christopher C. Lindsey, D. S. Johnston, 2022, Frontiers in Endocrinology.

Gene Expression During Development of Fetal and Adult Leydig Cells

M. Hardy, R. Ge, C. Sottas, 2007, Annals of the New York Academy of Sciences.

Approaches and limitations of phosphatidylinositol-3-kinase pathway activation status as a predictive biomarker in the clinical development of targeted therapy

A. Berkenblit, A. Strahs, S. Bacus, 2010, Breast Cancer Research and Treatment.

Analysis of the Human Sperm Proteome

D. Johnston, G. Kopf, Y. Qiu, 2005, Annals of the New York Academy of Sciences.

Evaluation of melphalan, oxaliplatin, and paclitaxel in colon, liver, and gastric cancer cell lines in a short-term exposure model of chemosaturation therapy by percutaneous hepatic perfusion.

Timothy P. Sheets, D. S. Johnston, Rajneesh P. Uzgare, 2013, Anticancer research.

Evaluation of Delcath Systems’ Generation 2 (GEN 2) Melphalan Hemofiltration System in a Porcine Model of Percutaneous Hepatic Perfusion

Timothy P. Sheets, E. Mcandrew, F. Moeslein, 2014, CardioVascular and Interventional Radiology.

Identification of Testis‐Specific Male Contraceptive Targets

D. Johnston, G. Kopf, J. Finger, 2007, Annals of the New York Academy of Sciences.